Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B
被引:30
|
作者:
Green, PM
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Green, PM
[1
]
Saad, S
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Saad, S
[1
]
Lewis, CM
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Lewis, CM
[1
]
Giannelli, F
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Giannelli, F
[1
]
机构:
[1] Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
A population-based study of hemophilia B mutations was conducted in the United Kingdom in order to construct a national confidential database of mutations and pedigrees to be used for the provision of carrier and prenatal diagnoses based on mutation detection. This allowed the direct estimate of overall (mu), male (v), and female (u) mutation rates for hemophilia B. The values obtained per gamete per generation and the 95% confidence intervals are mu = 7.73 (6.29-9.12) x 10(-6); v = 18.8 (14.5-22.9) x 10(-6); and u = 2.18 (1.44-3.16) x 10(-6). The ratio of male-to-female mutation rates is 8.64, with a 95% confidence interval of 5.46-14.5. The higher male rate was not caused by a much higher rate of transition at CpG sites in the male. Attempts to detect evidence of gonadal mosaicism for hemophilia B mutation in suitable families did not detect any instances of ovarian mosaicism in any of 47 available opportunities. This suggests that the risk of a noncarrier mother manifesting as a gonadal mosaic by transmitting the mutation to a second child should be <0.062.
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Giannelli, F
Anagnostopoulos, T
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
Anagnostopoulos, T
Green, PM
论文数: 0引用数: 0
h-index: 0
机构:
Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, EnglandGuys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England
机构:
Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, IranShahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, Iran
Parizadeh, Donna
论文数: 引用数:
h-index:
机构:
Moazzeni, Seyyed Saeed
Hasheminia, Mitra
论文数: 0引用数: 0
h-index: 0
机构:
Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, IranShahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, Iran
Hasheminia, Mitra
Khaloo, Pegah
论文数: 0引用数: 0
h-index: 0
机构:
Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, Iran
Univ Tehran Med Sci, Vali Asr Hosp, Sch Med, EMRC, Tehran, IranShahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, Iran
Khaloo, Pegah
论文数: 引用数:
h-index:
机构:
Mansournia, Mohammad Ali
论文数: 引用数:
h-index:
机构:
Azizi, Fereidoun
Momenan, Amir Abbas
论文数: 0引用数: 0
h-index: 0
机构:
Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, IranShahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, POB 19395-4763, Tehran, Iran